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ORIGINAL RESEARCH ARTICLE
Protein and small non-coding RNA-enriched
extracellular vesicles are released by the
pathogenic blood fluke Schistosoma mansoni
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Background: Penetration of skin, migration through tissues and establishment of long-lived intravascular
partners require Schistosoma parasites to successfully manipulate definitive host defences. While previous
studies of larval schistosomula have postulated a function for excreted/secreted (E/S) products in initiating
these host-modulatory events, the role of extracellular vesicles (EVs) has yet to be considered. Here, using
preparatory ultracentrifugation as well as methodologies to globally analyse both proteins and small non-
coding RNAs (sncRNAs), we conducted the first characterization of Schistosoma mansoni schistosomula EVs
and their potential host-regulatory cargos.
Results: Transmission electron microscopy analysis of EVs isolated from schistosomula in vitro cultures
revealed the presence of numerous, 30100 nm sized exosome-like vesicles. Proteomic analysis of these vesicles
revealed a core set of 109 proteins, including homologs to those previously found enriched in other eukaryotic
EVs, as well as hypothetical proteins of high abundance and currently unknown function. Characterization of
E/S sncRNAs found within and outside of schistosomula EVs additionally identified the presence of potential
gene-regulatory miRNAs (35 known and 170 potentially novel miRNAs) and tRNA-derived small RNAs
(tsRNAs; nineteen 5? tsRNAs and fourteen 3? tsRNAs).
Conclusions: The identification of S. mansoni EVs and the combinatorial protein/sncRNA characterization of
their cargo signifies that an important new participant in the complex biology underpinning schistosome/host
interactions has now been discovered. Further work defining the role of these schistosomula EVs and the
function/stability of intra- and extra-vesicular sncRNA components presents tremendous opportunities for
developing novel schistosomiasis diagnostics or interventions.
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S
chistosomes are parasitic flatworms responsible for
schistosomiasis, a neglected tropical disease currently
affecting approximately 230 million people found in
poverty-stricken areas of the developing world (1). This
chronic and debilitating disorder is initiatedwhen the aquatic
cercariae stage of the parasite’s lifecycle actively penetrates
human skin and transforms into a tissue-migrating schisto-
somulum. Upon penetration, the schistosomulum releases
excretory/secretory (E/S) products in a directed attempt to
simultaneously manipulate the host extracellular matrix,
to modulate host defensive barriers and to protect itself
from oxidative stress (2,3). Collectively, these E/S-driven bio-
logical processes ultimately enable a proportion of in-
fectious parasites to successfully continue their complex
migration throughout the human host, develop into
blood-dwelling dioecious adults and establish an infection

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that can last for years (4). As these E/S products need
to operate in the presence of harsh environmental stresses
within human tissue/blood, their packaging into pro-
tective transferable units would be advantageous for
sustaining bioactivity (5). An evolutionarily conserved
packaging system that has not been thoroughly investi-
gated in this aspect of schistosome biology is extracellular
vesicles (EVs).
Eukaryote EVs (exosomes and ectosomes) are between
30 and 1,000 nm in size (6,7) and are released from cells by
either the fusion of multivesicular bodies with the plasma
membrane (exosomes, 30100 nm) or by directly budding
from the plasma membrane (ectosomes, 1001,000 nm)
(711). During biogenesis, EVs protectively package intra-
cellular components (e.g. proteins, RNAs, lipids and protein/
RNA complexes) for extracellular release and short- or
long-distance intercellular communication (9,12). While
the molecular mechanisms underlying EV biogenesis and
cellular release are generally well understood, the processes
responsible for selective packaging of cargo destined
for intercellular communication and the uptake of these
packages by recipient cells is likely to vary among different
cell types or organisms analysed (13). Among EV cargos,
there is growing evidence that certain miRNA, lipid and
protein species are found enriched in certain vesicle types
(e.g. 12). This implies that EVs (and their packages) may
regulate specific cell-to-cell, organ-to-organ, individual-
to-individual or pathogen-to-host signalling, potentially
playing a central role in many important biological pro-
cesses (14). In terms of parasites, the role of protozoan-
derived EVs in mediating horizontal gene transfer and
immunomodulation has been hypothesized for a variety
of species (15). Within the metazoan endoparasites, recent
investigations of Echinostoma caproni, Fasciola hepatica,
Dicrocoelium dendriticum, Schistosoma japonicum, Opis-
thorchis viverrini, Heligmosomoides polygyrus and Trichuris
suis have demonstrated that EVs are excreted/secreted
from helminths and may be taken up by host cells (1621).
Based on the growing realization that EVs facilitate inter-
cellular communication in eukaryotes and are excreted/
secreted from related platyhelminths, we hypothesized that
they are important players in the initiation and main-
tenance of long-lived host/parasite interactions during
schistosomiasis.
Here, for the first time, we isolate EVs derived from
Schistosoma mansoni schistosomula E/S products and
characterize their protein and small non-coding RNA
(sncRNA) components. While our findings highlight a
rich repository for infection-related biomarkers, they also
identify an entirely new strategy by which schistosomes
likely manipulate host defensive barriers. Further ex-
ploration of these vesicles’ functions may identify novel
strategies for schistosomiasis control.
Materials and methods
Ethics statement
All procedures performed on mice adhered to the United
Kingdom Home Office Animals (Scientific Procedures)
Act of 1986 (project license PPL 40/3700) as well as
the European Union Animals Directive 2010/63/EU and
were approved by Aberystwyth University’s (AU) Animal
Welfare and Ethical Review Body.
Parasite material
A Puerto Rican strain (NMRI) of S. mansoni was used
throughout the study and passaged between Mus musculus
(Tuck Ordinary, TO) and Biomphalaria glabrata (NMRI
albino and pigmented hybrid) hosts. Cercariae were shed
from both B. glabrata strains by exposure to light in an
artificially heated room (268C) for 2 h. Collected cercariae
were mechanically transformed into schistosomula accord-
ing to established methodologies (22) and resuspended
in culture medium containing DMEM (Dulbecco’s Mod-
ified Eagle Medium, Sigma-Aldrich, Dorset, UK), 4.5 g/l
glucose, 2 mM L-glutamine, 200 U/ml penicillin and
200 mg/ml streptomycin (all Sigma-Aldrich) with or with-
out 10% v/v foetal calf serum (FCS, Sigma-Aldrich).
All schistosomula (7,500 individuals/ml) were cultivated
at 378C and left to develop for 72 h in a humidified
atmosphere containing 5% CO2.
EV purification
EVs were purified by differential centrifugation of 72 h
schistosomula E/S products as previously described (23)
with slight modifications. Briefly, the schistosomula cul-
ture supernatant (containing E/S products) was collected
and centrifuged at low speed (500g for 2 min, 48C) to
remove remaining parasites and then sequentially centri-
fuged at a higher speed (700g for 20 min, 48C) to remove
any residual debris. This resulting ‘‘pre-cleared’’ super-
natant was subsequently centrifuged at 120,000g for
80 min at 48C on an OptimaTM L-100 XP ultracentrifuge
(Beckman Coulter, High Wycombe, UK) using a Type
70 Ti rotor. The EV-enriched pellet was washed 3 times
in phosphate buffered saline (PBS, pH 7.4) and finally
resuspended in 100 ml of PBS. The EV-depleted super-
natant was concentrated to 500 ml using a 5 k MWCO filter
(Amicon, Fisher Scientific, Loughborough, UK), washed
2 times by diluting with 2 ml PBS and reconcentrated to
500 ml. Both EV-enriched and EV-depleted samples were
stored at 808C until further use.
Scanning electron microscopy
Intact cercariae were prepared as previously described (24).
In brief, parasites were fixed in 4% glutaraldehyde/4%
paraformaldehyde for 24 h at 48C, washed in PIPES buffer
(pH 7.2) for 4 h at 48C, incubated in 1% osmium tetroxide
(1 h at 48C), rewashed in PIPES buffer and deposited on
poly-L-lysine coated coverslips prior to dehydration and
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critical point drying. After critical point drying, parasite
samples were mounted onto scanning electron microscope
(SEM) stubs, sputter coated with gold/palladium and
visualized with a Philips XL 30 FEG SEM.
Transmission electron microscopy
Schistosomula EV preparations were qualitatively as-
sessed for size and shape by transmission electron micro-
scopy (TEM). Briefly, a 25 ml aliquot of each EV-enriched
sample was fixed with an equal volume of 4% glutaralde-
hyde, adsorbed onto Formvar/carbon-coated copper grids
and stained with 2% uranyl acetate (pH 4). Processed
EV samples were subsequently visualized on a Jeol 1010
transmission electron microscope operated at 60 kV and
30,000magnification. Images were recordedwith a Kodak
MegaPlus camera Model 1.4i, visualized by analySIS
3.1 software and processed on ImageJ.
Helminth fluorescent bioassay and
fluorescent microscopy
Schistosomulaviability in each culture condition (incomplete
medium, complete medium or heat inactivated at 658C for
10 min) was assessed at 72 h as previously described (25).
Briefly, after washing the parasites with DMEM, propidium
iodide (PI; 544 nm excitation/620 nm emission; 2.0 mg/ml)
and fluorescein diacetate (FDA; 485 nm excitation/520 nm
emission; 0.5 mg/ml) were simultaneous added to each
schistosomula sample. Fluorescent data were collected
from a BMG Labtech Polarstar Omega plate reader
(Durham, NC, USA) and converted into percent viability
values. Fluorescent images of FDA/PI co-stained parasites
were obtained from an ImageXpress micro widefield high
content screening system (Molecular Devices, Woking-
ham, UK) with bright field and FITC-TRITC filter set.
FDA and PI images were merged and analysed using
ImageJ. Micron-sized vesicles released from in vitro
cultured schistosomula labelled with FDA were visualized
at 40 magnification using a Leica Axioplan (Milton
Keynes, UK) microscope equipped with an FITC (494 nm
excitation) filter and a mercury vapour light source. A
Hamamatsu CA74295 camera (Welwyn Garden City, UK)
with Wasabi Version 1.4 software was used to capture
photographic images of stained schistosomula.
Proteomics
EV-enriched fractions (n4) were centrifuged for 1 h
at 100,000g at 48C (TL-100 ultracentrifuge, Beckman
Coulter, Inc., Fullerton, CA, USA). Pellets were dissolved
in 50 mM TEAB buffer (triethylammonium bicarbonate,
pH 8.5) containing 1% RapiGest (Waters, Milford, MA,
USA). Reduction and alkylation of cysteine was per-
formed using 2 mM TCEP (tris(2-carboxyethyl)phosphine,
1 h at 608C) and 4 mM MMTS (methyl methanethiosul-
fonate, 15 min at room temperature with constant shaking),
respectively. Then, 5 mg of trypsin (Sequencing Grade
Modified Trypsin, Promega, Madison, WI, USA) was
added and proteins were digested overnight at 378C.
Samples were subsequently acidified to pHB2 using
10% TFA, incubated at 378C for 30 min and centrifuged at
16,000g for 10 min. The supernatant was concentrated
to approximately 20 ml in a vacuum concentrator and
stored at 208C prior to mass spectrometry analysis.
Peptides were injected onto a trap column (Acclaim
PepMap100, 100 mm2 cm; nanoViper C18, 5 mm, 100 A˚;
Thermo Fisher Scientific, Waltham, MA, USA) equili-
brated with 0.1% formic acid and separated on an ana-
lytical reverse phase column (Acclaim PepMap RSLC
75 mm50 cm; nanoViper C18, 2 mm, 100 A˚; Thermo
Fisher Scientific) coupled to an ion trap mass spectrometer
(amaZon Speed, Bruker Daltonics, Bremen, Germany) at a
flow rate of 300 nl/min. The liquid chromatography was
performed with a piece-linear gradient (010 min at 2% B,
1025 min to 5% B, 25165 min to 25% B, 165175 min to
30% B, 175190 min to 35% B, 190195 min to 100% B,
195210 min at 100% B, where B is 95% acetonitrile/
0.1% formic acid). For mass spectrometric analysis, ions
were generated using CaptiveSpray (Bruker Daltonics) at
a spray voltage of 1.3 kV. The temperature of the heated
capillary was set to 1508C. Tandem mass spectrometry
was performed in a data-dependent manner, selecting
the 10 highest peaks in an MS spectrum. Masses were
excluded for 1 min after MS/MS was performed.
Peak lists from the 4 EV samples were generated using
Data analysis 4.0 (Bruker Daltonics) with default settings
and were exported as Mascot Generic Files. Peptides
were identified in the S. mansoni database (v4.0; 13,193
sequences; 5,894,147 residues) using the Mascot algorithm
(Mascot 2.5, Matrix Science, London, UK). An MS toler-
ance of 0.5 Da (with the number of 13C1) and an MS/
MS tolerance of 0.5 Da were used. Trypsin was designated
as the enzyme and up to 1 missed cleavage site was
allowed. Beta-methylthiolation of cysteine was selected
as a fixed modification and oxidation of methionine as a
variable modification. Data were exported as XML files
at a target false discovery rate for peptide identification of
1% (using a target/decoy approach). The XML files were
then analysed using an in-house script, selecting only
peptides corresponding to the highest peptide-spectrum
match (Rank 1 peptides) with a Mascot score above 25.
For the generation of the overall list of proteins identified
(Supplementary file 1), only proteins with at least 2 unique
peptides were selected. From this list, only proteins identi-
fied in 3 out of the 4 biological replicates were considered
as schistosomula extracellular vesicle proteins.
DNA microarray transcription profiles
Data from the 37,632 element S. mansoni long-
oligonucleotide DNA microarray studies of Fitzpatrick
et al. (26) were interrogated to find the transcription pattern
corresponding to the 72 h schistosomula EV proteome
across 14 life-cycle stages. Briefly, log2 normalized gene
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expression data was obtained for 102 of the 109 EV pro-
teome components (unique 50-mer oligonucleotides for
7 Smps were not present on the DNA microarray; Supple-
mentary file 2) and subjected to hierarchical agglomera-
tive clustering (Euclidean distance and complete linkage)
using the R statistical programming language (27) and the
Bioconductor (28) package gplots. A full set of raw and
normalized data is available via ArrayExpress under the
experimental accession number E-MEXP-2094.
RNA extraction, sncRNA library preparation
and sequencing
Total RNA was extracted from 100 ml EV-enriched (n3)
and 100 ml EV-depleted (n3) schistosomula E/S samples
using the miRNeasy kit (Qiagen, Dorking, UK) accord-
ing to the manufacturer’s instructions. The profile of the
small RNA samples was assessed with a Bioanalyzer
small RNA chip (Agilent Technologies, Santa Clara, CA,
USA). Small RNA concentrations ranged from 60 pg/ml
(EV-enriched fraction) to 750 pg/ml (EV-depleted frac-
tion) as determined by the Bioanalyzer.
sncRNA libraries were prepared using the NEBNext
Multiplex Small RNA Library Prep Set and NEBNext index
primer for Illumina (New England Biolabs, Ipswich, MA,
USA), according to the manufacturer’s protocol. Size selec-
tion of the polymerase chain reaction (PCR) products was
performed using 6% non-denaturing polyacrylamide gel
electrophoresis, and bands between 130 and 200 bp were
recovered following gel extraction. HiSeq 100 bp single end
Illumina sequencing was performed at the AU Translational
Genomics facility using the HiScanSQ platform. Raw reads
were deposited at the NCBI sequence read archives under
the accession number SRP057687.
microRNA detection and annotation
The miRDeep2 package (29) was used to identify known
and putative novel miRNA present in the EV-enriched
and EV-depleted compartments of schistosomula E/S. After
cleaning the reads with Trimmomatic (30), trimmed se-
quences of at least 16 nucleotides long were pre-processed
(i.e. aligned) against the S. mansoni genome v5.2 (31) using
the mapper module of miRDeep2 (utilizing bowtie) with
default options that included discarding reads shorter than
18 bp, collapsing reads and mapping reads without any
mismatches. These stringent criteria resulted in low numbers
of mapped reads. Weakening the criteria to allow mismatches
greatly increases the proportion of mapped reads identified
(e.g. 60% or more depending upon the criteria selected).
Unmapped reads (at any criteria) included a high propor-
tion of low complexity regions. Identification of miRNAs
was performed with the miRDeep2.pl script, including
quantification and expression profiling performed by
the Quantifier module. Known precursor S. mansoni
miRNAs as well as mature miRNA sequences derived
from 5 platyhelminth species (Schmidtea mediterranea,
Echinococcus granulosus and Echinococcus multilocularis,
Schistosoma japonicum and S. mansoni) were provided to
the miRDeep2.pl script from miRBase (release 21). Outputs
from both the Quantifier and miRDeep2 were merged
and 2 filtering steps were applied to generate a final list of
identified miRNAs: (a) only those miRNAs displaying a
log-odd score above 0 and (b) only those miRNAs displaying
at least 10 reads in 2 out of the 3 biological replicates
(EV-enriched or EV-depleted fractions) were kept (Supple-
mentary file 3). Library size scaling factors were calculated
for each sample and miRNA datawere normalized following
the protocol of Anders et al. (32) using the R statistical
programming language (27) and the Bioconductor (28)
package DESeq2 (33). The Quantifier module maps reads
to predefined miRNA precursors derived from miRBase;
however, some of these miRNAs could not be mapped
to the current S. mansoni genome assembly (v5.2).
tRNA-derived small RNA detection and
annotation
Trimmed reads (passing QC metrics) ranging from 1 to 95
nucleotides (size range of inserts in our sncRNA libraries)
were mapped to the S. mansoni tRNA database (depleted
of mitochondrial and pseudo-tRNA sequences) obtained
from GeneDB ((34); accessed Nov-2014) using BLAST.
As a first filter, only reads displaying a top BLAST hit
with 100% sequence identity and an alignment covering
90% of their sequence length were retained (dashed line,
Fig. 6a). Reads mapping to tRNA sequences encoding for
the same tRNA type, but containing different anticodon
sequences, were combined. This processing step was per-
formed to reduce the complexity of mapping reads to
1,099 genomic loci encoding tRNAs (current number of
tRNA genes in the S. mansoni genome, v5.2). It allowed
us to identify the predominant tRNA types (from the 20
ubiquitous tRNAs, selenocysteine tRNA and suppressor
tRNA) present in our E/S fractions. As a second filter,
these reads were processed using an in-house script
to identify both 5? and 3? tRNA-derived small RNAs
(tsRNA) composed of both tRNA halves (tiRNAs) and
tRNA fragments (tRFs) (35,36). Here, reads of at least
11 bp were classified as follows: (a) as a 5? tsRNA if
the alignment started at Position 1 in the mature tRNA
and ended at or before Position 35; (b) as a 3? tsRNA if
the alignment started at the last position in the tRNA
and extended 1130 bp or 4050 bp towards the 5? end
(solid line, Fig. 6b). Mature 3? tsRNA reads (containing
a terminal CCA-3? anchor) were subsequently quantified
using similar processing, except that the tRNAs from
GeneDB were modified by adding a CCA anchor to their
3? end before performing the BLAST alignments. Only
tsRNA fragments containing at least 10 reads in 2 out of
the 3 biological replicates (EV-enriched or EV-depleted frac-
tions) were kept. Data normalization on these tsRNAs
was performed following the procedures described for
the miRNA analysis above.
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Results and discussion
In vitro cultivated S. mansoni schistosomula
excrete/secrete EVs
To investigate whether S. mansoni produces exosome-
like EVs, we specifically examined a lifecycle stage that
actively excretes/secretes copious amounts of parasite pro-
ducts, the tissue-migrating schistosomula (37). This choice
maximized our chances of finding excreted/secreted nano-
sized vesicles in culture supernatants derived from in vitro
cultivated schistosomes (Fig. 1). Epifluorescent micro-
scopy of FDA (an esterase substrate) labelled schistoso-
mula as well as TEM of cercaria clearly demonstrated that
these lifecycle stages produce micron-sized vesicles from
their anterior ends (Fig. 1a), a phenomenon that has been
previously documented (38). It is these secretory products,
originating from schistosomula unicellular acetabular or
head glands (39) and accumulating throughout the culti-
vation period, that represented a rich source of starting
material (in addition to tegumental contributions) for the
first isolation and characterization of nanosized exosome-
like EVs in S. mansoni.
As FCS is a potential source of contaminating bovine
EVs (40) and a downstream confounding variable for the
identification of parasite-derived EV-associated proteins
and sncRNAs, we first determined the viability of schisto-
somula cultivated in media lacking FCS (Fig. 1b). Here,
parasites cultured in the absence of FCS for 72 h were
phenotypically normal (motile, non-granular) and demon-
strated similar viability values (95%) when compared to
the control (91%) schistosomes cultured in the presence
of FCS (Student’s t-test, one-tailed; p0.2). Therefore,
the lack of FCS in the cell culture media did not negatively
affect the viability of 72 h cultivated schistosomula. Pre-
paratory ultracentrifugation of E/S products derived from
these 72 h schistosomula cultures (-FCS) and TEM of
the pelleted vesicles demonstrated morphological features
(sizes ranging between 30 and 100 nm in diameter) con-
sistent with exosomes (Fig. 1c). These vesicles were not
observed (according to the limits and resolution of TEM)
in the EV-depleted, schistosomula E/S fractions. Because
these schistosomula nanovesicles potentially represent novel
modulators of host/parasite interrelationships, their pro-
teomic and sncRNA content was explored by liquid
chromatography coupled to tandem mass spectrometry
(LC-MS/MS) and sncRNA-seq analyses.
Schistosomula EV proteomes contain a collection
of conserved vesicle biomarkers and unique
parasite components
Proteomic analyses of schistosomula EV-enriched fractions
identified 109 proteins that were reproducibly detected (see
Materials and methods) in 4 independently collected parasite
samples (Table I and Supplementary file 1). When we com-
pared them to a collated set of previously annotated
eukaryote EV proteomes (12), we found entries in common
with our schistosomula dataset including (not exclusive)
tetraspanins (Smp_181530, Smp_173150), heat shock pro-
teins (Smp_106930), annexins (Smp_077720, Smp_045500,
Smp_074140, Smp_045560 and Smp_045550), Rab11 pro-
teins (Smp_005670, Smp_104310 and Smp_173990), 14-3-3
isoforms (Smp_009760, Smp_002410 and Smp_034840.1),
cytoskeletal proteins (e.g. Smp_066760, Smp_046600 and
Smp_202970.1) and metabolic enzymes (e.g. Smp_054160,
Smp_056970.1 and Smp_102070). These proteomic data
strongly support our TEM interpretations (Fig. 1) and
indicate that the nanovesicles isolated from in vitro schisto-
somula cultures are indeed exosome-like EVs (in compar-
ison to apoptotic bodies or ectosomes). Measuring these
data against previous proteomic investigations of schistoso-
mula E/S products (37,41), we find an overlapping subset
(20%; 22/109) of atypical E/S proteins (e.g. absence of
a signal peptide, as predicted by SignalP 4.1 (42); performed
May 2015) also present in our EV dataset (e.g. Smp_046600,
actin; Smp_106930, hsp70; Smp_054160, GST28; Smp_
008070, thioredoxin; Smp_024110, enolase; Smp_095360.1,
fatty acid binding protein; Smp_040130, cyclophilin; Smp_
056970.1, GAPDH; Smp_214190, calpain; Smp_042160.2,
fructose bisphosphate aldolase; Smp_086480, SmTAL2;
Smp_086530, SmTAL3; Smp_003990, triosephosphate
isomerase 1a). While holocrine secretion, schistosomula
damage or cultivation conditions could be responsible for
the presence of these ‘‘cytosolic’’ proteins in E/S pro-
teomes, our results now provide an alternative explanation
and indicate that schistosome EVs are a vehicle for non-
classical protein excretion/secretion.
Further sequence comparisons to EV proteomes de-
rived from related F. hepatica (hermaphroditic liver
fluke), E. caproni (hermaphroditic intestinal fluke) and
D. dendriticum (hermaphroditic liver fluke) trematodes
(16,17) revealed a common subset of proteins involved
in metabolic processes (e.g. enolase, glyceraldehyde 3-
phosphate dehydrogenase, fructose bisphosphate aldolase),
calcium binding (e.g. calcium binding proteins) and struc-
ture (e.g. actin and annexin). When differences were found
(e.g. F. hepatica EVs contain large numbers of pro-
teases whereas E. caproni, D. dendriticum and S. mansoni
schistosomula do not), divergent life histories (hermaph-
roditic vs. dioecious lifecycles; liver vs. intestine vs. blood
residency) or compared developmental stages (F. hepatica,
D. dendriticum and E. caproni adults vs. S. mansoni larvae)
were likely responsible. Indeed, it is well-established that
EVs derived from different cellular sources contain dis-
tinct subsets of proteins linked to specific cell-associated
activities (6,43). Therefore, functional characterization
of the 15 hypothetical (not conserved) proteins identified
in the schistosomula EV proteome (Supplementary file 1)
may provide important insight into how these particular
vesicle components specifically influence schistosome
infection, migration and development.
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Extending our schistosomula EV proteome interroga-
tion further, we utilized both gene ontology (GO) (44)
and existing DNA microarray (26) datasets to quantify
functional category enrichment as well as to predict
whether these particular proteins could be found in EVs
derived from other schistosome lifecycle stages (Fig. 2).
Fig. 1. Schistosoma mansoni excretes/secretes exosome-like extracellular vesicles (EVs) during in vitro cultivation. (a) Microscopic
analysis of infective stage cercariae (scanning electron microscopy  left panel) and tissue-migrating schistosomulum (epifluorescent
microscopy of fluorescein diacetate labelled parasites  right panel) demonstrates the excretion/secretion of micron-sized vesicles
(highlighted by white rectangle boxes). To determine whether EVs were present in these (or other) excreted/secreted (E/S) products,
we specifically examined the supernatant of 72 h in vitro cultivated schistosomula. (b) Parasite viability was assessed at 72 h using the
helminth fluorescent bioassay (HFB) (25) (n11) in cultures containing or lacking foetal calf serum (FCS, a source of contaminating
bovine EVs (40)) compared to heat-killed controls. Error bars represent the standard deviation of the mean. Student’s t-test was used to
assess differences in viability between the schistosomula cultures. High content imaging (FITC and TRITC filters, 10magnification)
of fluorescently co-labelled schistosomula (fluorescein diacetate, green and propidium iodide, red) supports the HFB measurements.
(c) EVs were isolated from E/S products by ultracentrifugation of the 72 h schistosomula culture supernatant (-FCS) and analysed by
transmission electron microscopy at 30,000magnification.
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GO analyses of these 109 schistosomula EV proteins
using g:Profiler (45) indicated that 11 categories (5 within
biological processes, 6 within molecular function but
none within cellular component) were significantly over-
represented when compared to a background dataset
comprised of all electronically GO-annotated S. mansoni
proteins (ENA assembly version ASM23792v2) (Fig. 2a).
Interestingly, 2 of these 5 ‘‘biological process’’ categories
(small GTPase-mediated signal transduction and protein
transport) were also found over-represented in a recent






Protein IDb GeneDB productb 1 2 3 4 1 2 3 4 peptidese
Smp_074560 Hypothetical protein 117 84 163 128 22 21 22 18 492
Smp_066760.1 Merlin:moesin:ezrin:radixin 70 46 112 73 25 21 28 18 301
Smp_141760 Hypothetical protein 72 44 74 65 9 9 12 9 255
Smp_106930 Heat shock protein 70 64 42 56 53 25 19 15 16 215
Smp_178290 Hypothetical protein 52 35 55 46 6 7 8 7 188
Smp_072190 Membrane associated protein 29 23 10 35 33 4 4 5 4 101
Smp_009760 14-3-3 protein homolog 1 30 14 26 19 10 8 12 7 89
Smp_046600 Actin 19 20 18 21 9 11 8 6 78
Smp_005670 Rab11 16 7 16 26 10 5 7 8 65
Smp_074570 Hypothetical protein 15 13 18 18 4 4 4 3 64
Smp_034840.1 14-3-3 protein epsilon 20 13 17 12 12 9 9 7 62
Smp_174520 Dynein light chain 9 26 13 13 3 3 3 3 61
Smp_054160 Glutathione S-transferase 28 kDa (GST 28)
(GST class-mu), putative
18 10 16 16 11 5 5 4 60
Smp_062080 Serine protease inhibitors serpins 19 10 11 13 10 8 6 4 53
Smp_181530 CD63 antigen 9 8 25 11 3 4 6 3 53
Smp_008070 Thioredoxin 20 7 14 11 9 5 6 4 52
Smp_056970.1 Glyceraldehyde 3 phosphate dehydrogenase 22 10 11 7 9 7 4 4 50
Smp_170820 ATP binding cassette subfamily B (MDR:TAP) 16 9 15 10 11 7 8 7 50
Smp_179930 Syntaxin 1a 11 9 15 12 6 5 8 4 47
Smp_024110 Enolase 14 7 13 12 8 6 6 6 46
Smp_036470 Oxalate:formate antiporter 12 11 12 11 3 2 2 3 46
Smp_032980 Calmodulin protein 13 6 10 13 3 3 2 3 42
Smp_121950 hypothetical protein 9 15 8 9 8 11 5 4 41
Smp_194770 Taurocyamine kinase; creatine kinase;
arginine kinase
26 8 1 3 15 8 1 3 38
Smp_018530.1 Nascent polypeptide associated complex subunit 12 7 12 6 8 5 3 3 37
Smp_032990 Calmodulin 4 (Calcium binding protein Dd112) 10 8 7 12 3 2 2 3 37
Smp_008490 Glycogenin 1 6 6 13 9 5 6 5 3 34
Smp_046690 Polyubiquitin C 10 6 11 7 3 3 3 3 34
Smp_095360.1 Fatty acid binding protein 9 7 8 9 6 4 2 2 33
Smp_214190 Calpain 10 12 7 3 9 10 4 2 32
Smp_009780.1 14-3-3 protein, putative 9 4 10 8 5 3 4 4 31
Smp_035260.1 Epidermal growth factor receptor kinase 9 11 5 6 8 7 4 4 31
Smp_077720 Annexin 9 10 7 5 5 7 4 3 31
Smp_104310 Rab11 5 7 11 7 5 6 4 4 30
Smp_045500 Annexin 11 6 8 4 7 3 3 2 29
aAll 109 proteins reproducibly detected (see Materials and methods) in schistosomula EVs are found in Supplementary file 1. bSystematic
name (Smp) and gene product identifier as indicated in GeneDB (release 5.2 at www.genedb.org). cNumber of peptides found for each
Smp in each of the 4 replicates. dNumber of unique peptides found for each Smp in each of the 4 replicates. eTotal number of peptides
found for each Smp in all 4 replicates (surrogate for protein abundance).
Protein and small non-coding RNA-enriched schistosome EVs
Citation: Journal of Extracellular Vesicles 2015, 4: 28665 - http://dx.doi.org/10.3402/jev.v4.28665 7
(page number not for citation purpose)
Fig. 2. Schistosomula EVs contain vesicular-enriched functional components and include proteins likely to be found in EVs derived
from other schistosome lifecycle stages. EVs were isolated from 72 h schistosomula cultures using preparative ultracentrifugation (23).
Pelleted EVs (n4) were digested with trypsin and subsequently prepared for liquid chromatographytandem mass spectrometry. Only
proteins represented by 1 or more unique peptides in 3 out of the 4 replicates (with 1 of these replicates having to contain at least
2 unique peptides) were considered as schistosomula EV proteins. (a) Bar chart representation of significantly enriched gene ontology
(GO) categories found in EV proteomes analysed by g:Profiler (45) using BenjaminiHochberg false discovery rate detection and
best per-parent GO identifier (moderate). (b) Expression profiling of the genes (derived from 102/109 Smps) encoding EV proteome
components throughout the schistosome life cycle (Supplementary file 2). DNA microarray data (log2 normalized gene expression
values) obtained from Fitzpatrick et al. (26) was subjected to agglomerative hierarchical clustering (Euclidean distance and complete
linkage) and illustrated as a heat map. The dashed rectangular box represents the 72 h schistosomula lifecycle stage.
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GO meta-analysis of proteins commonly found in human
EVs (12). While this analysis provides additional evi-
dence supporting the classification of these schistosomula
vesicles as EVs, characterization of EV proteomes derived
from other schistosome lifecycle stages is necessary to
fully describe their functional diversity.
To determine if the 72 h schistosomula EV proteome
(Supplementary file 1) simply reflected the most abun-
dantly expressed genes found within this lifecycle stage, we
quantified transcription data for these 109 gene products
from a recently published schistosome DNA microarray
study (26). This analysis (Fig. 2b, dashed vertical box, and
Supplementary file 2) revealed that 72 h schistosomula EVs
contained proteins derived from both highly and lowly
expressed genes. While caution must be taken in extra-
polating the abundance of transcripts derived from whole
schistosomula transcriptomes to schistosomula EV pro-
teomes, our finding is in line with current thinking about
the biogenesis of EVs, which indicates that protein pack-
aging is governed by controlled endovesicular sorting
mechanisms, independent of abundance (46). These sort-
ing mechanisms involve the co-operation of hsp70/hsp90
chaperones, 14-3-3 epsilons, tetraspanins and protein kinases
(47). The presence of these proteins in EVs derived from
72 h cultivated schistosomula as well as their ubiquitous
expression throughout the parasite’s lifecycle (Supplemen-
tary file 2) indicates that this conserved packaging mec-
hanism may also be operational within schistosomes.
How many additional proteins identified in our current
study are also found in EVs derived from other schisto-
some lifecycle stages awaits further investigation. Our gene
expression analyses predict that there may be overlap
(Fig. 2b).
Schistosomula E/S products contain miRNAs
found within and outside EVs
Recent studies have demonstrated that helminth parasites
excrete/secrete sncRNAs (17,18), with the most detailed
analysis to date indicating that 78% of the sncRNA E/S
fraction of H. polygyrus (B30 nucleotides) is composed
of miRNAs (18). Because of these findings, we hypothe-
sized that schistosomula E/S products would also contain
detectable miRNA and, potentially, other sncRNA classes
that could be present within or outside the pelleted EVs
produced during our in vitro culture conditions (Fig. 1).
Therefore, we performed a sncRNA RNA-seq analysis of
schistosomula EV-enriched (Fig. 1c) and EV-depleted E/S
fractions.
Applying standard quality control measures and
stringent S. mansoni genome (version 5.2) mapping
(see Materials and methods) to these 6 RNA-seq libraries
(EV-enriched fraction, n3; EV-depleted fraction, n3)
led to similar average numbers of reads/fraction available
for miRNA analyses (Table II). Within the complete (EV-
enriched and EV-depleted fractions) schistosomula E/S
miRNA-ome, we identified 35 previously characterized
platyhelminth miRNAs (known) and 170 potentially novel
S. mansoni miRNAs (sma-miRNAs, having no seed sequence
similarity to any previously characterized platyhelminth
miRNA as determined by miRDeep2) in total (Fig. 3 and
Supplementary file 3). These 205 sma-miRNAs could
be segregated into those that were found in comparable
abundance (114 miRNAs) between EV-enriched and
EV-depleted fractions (Cluster 1), those more abundant
(51 miRNAs) in EV-enriched fractions (Cluster 2) and
those more abundant (40 miRNAs) in EV-depleted frac-
tions (Cluster 3) (Fig. 3a). The genomic origin of these
205 E/S-derived schistosomula sma-miRNAs (vertical
black lines) was distributed across both autosomes and
sex-defining chromosomes (allosomes) in a proportion no
different than the distribution of all known sma-miRNAs
deposited in miRBase (vertical grey lines) (Fig. 3b) (p0.05,
Fisher’s exact test). This suggests that, while excretion/
secretion of these gene-regulatory RNAs may be a directed
and carefully controlled process (48), E/S inclusion of sma-
miRNAs is independent of autosome/allosome source.
Among the 35 known sma-miRNAs identified in the
schistosomula E/S products (Fig. 4), sma-bantam, sma-miR-
10, sma-miR-3479 and sma-miR-n1 were all previously
Table II. Small non-coding (snc) RNA-seq library statisticsa
EV-enriched EV-depleted
Sample 1 Sample 2 Sample 3 Average Sample 1 Sample 2 Sample 3 Average
Sequencing reads 19047516 1513874 19343559 13301649.7 14862082 10796578 15789214 13815958
QC passed reads 9883599 642923 8910859 6479127.0 4954797 4627229 6852520 5478182
Mapped to SMA genome
(mapper/miRNA analysis)
774495 41172 239113 351593.3 373093 400418 354513 376008
aSequencing was performed on E/S samples (n3) derived from mechanically transformed schistosomula cultured for 72 h. Total RNA
from EV-enriched and EV-depleted fractions was extracted using the miRNeasy kit (Qiagen), made into NGS libraries using NEBNext
reagents (New England Biolabs) and sequenced on an Illumina HiScanSQ platform (single end 100 bp reads). Trimming was performed
with Trimmomatic 0.30 and quality control assessed using FastQC. Mapping of reads to the S. mansoni genome (v5.2) within miRDeep2
was performed by the Mapper module.
Protein and small non-coding RNA-enriched schistosome EVs
Citation: Journal of Extracellular Vesicles 2015, 4: 28665 - http://dx.doi.org/10.3402/jev.v4.28665 9
(page number not for citation purpose)
detected in sera obtained from individuals (mice, humans
or rabbits) chronically infected with S. mansoni (49,50).
While none of the newly identified 170 sma-miRNAs have
yet been detected in infected sera, their presence should
be investigated due to their high abundance in schistoso-
mula E/S products (Fig. 5 and Supplementary file 3).
Nevertheless, our findings now indicate a potential mecha-
nism, larval excretion/secretion of known and novel
miRNAs, by which these sma-miRNAs are released from
schistosomes and accumulate in host blood. The discovery
that sma-bantam, sma-miR-10, sma-miR-3479 and sma-
miR-n1 (among numerous novel sma-miRNAs) are found
Fig. 3. Schistosomula excrete/secrete extracellular miRNAs. Supernatant from 72 h in vitro cultured schistosomula was separated into
EV-enriched and EV-depleted fractions (n3) by preparatory ultracentrifugation. Total RNA from each fraction was extracted using
the miRNeasy kit (Qiagen) and prepared for RNA-seq using the NEBNext Small RNA (for Illumina HiSeq sequencing) kit. To identify
sma-miRNAs in our samples, the miRDeep2 package was utilized (29). Only miRNAs with at least 10 reads in 2 out of the 3 biological
replicates (in at least one of the fractions, EV-enriched OR EV-depleted) were considered in the study. A total of 205 putative sma-
miRNAs passed this criterion. sma-miRNA read count data were normalized using the DESeq2 package (33) as described in
the Materials and methods. (a) Heatmap depiction of sma-miRNA abundance (represented by Z-scores) found within EV-enriched
and EV-depleted supernatant fractions after agglomerative hierarchical clustering and standardization. Each row represents a miRNA
and its relative Z-score value in EV-enriched and EV-depleted fractions is displayed in the 2 columns. All sma-miRNA specifics (name,
sequence, raw/normalized read counts and cluster location) are included in Supplementary file 3. (b) sma-miRNA localization found
throughout the S. mansoni karyotype (v5.2). Vertical grey bars represent the position of known sma-miRNAs available in miRBase
(v.21). Vertical black bars represent the localization of all extracellular sma-miRNAs (within EV-depleted and EV-enriched fractions)
newly identified in our study. Black stars above the vertical lines represent 13 sma-miRNAs found in our study that are also present in
miRBase. Eighteen miRNAs localized on unmapped scaffolds (16 not mapped at all; 1 unplaced on Ch 7, 4 and 3; 5 unplaced on Ch 1)
as well as 15 miRNAs not yet mapped to the current S. mansoni genome assembly were not included in this analysis. All available sma-
miRNA localization coordinates are available in Supplementary file 3.
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in similar abundance between EV-enriched and EV-
depleted E/S fractions (Figs. 4a and 5a) would suggest
that, in addition to EV encapsulation, serum-detectable
sma-miRNAs could be stabilized by protein interactions.
Alternatively, the comparable abundance of these (and other,
Supplementary file 3) miRNAs found within EV-enriched
Fig. 4. Most of the 35 known miRNAs released by schistosomula are found in comparable abundance between EV-enriched and EV-
depleted fractions. Outputs from the miRDeep2.pl script within the miRDeep2 package were used to identify known platyhelminth
miRNAs in schistosomula E/S samples. Manual curation against the recent literature (49,51,53) was also performed to identify
previously described miRNAs that have not yet been uploaded to miRBase. A total of 35 known miRNAs were subsequently identified.
(a) Known sma-miRNAs (26) found at similar abundance between EV-enriched (dark bars) and EV-depleted (light bars) fractions. (b)
Known sma-miRNAs (9) found at a higher relative proportion in the EV-enriched (black bars) or the EV-depleted (grey bars) fraction
(i.e. containing reads only in the EV-enriched or EV-depleted fractions after normalization). The asterisk (*) represents sma-miRNAs
(sma-mir-76 and sma-mir-2149) identified by seed sequence similarity to Schmidtea mediterranea sme-miRNAs. Bar charts represent the
miRNA log2 normalized read counts for each sample where the indicated sma-miRNA was found (see Materials and methods). Raw
and processed sma-miRNA read data are found in Supplementary file 3.
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and EV-depleted E/S fractions could also be indicative
of vesicle lysing during the 72 h in vitro cultures. Until a
time in which these 2 scenarios are resolved (using dif-
ferential proteinase K and RNase A processing of EVs),
quantitative reverse-transcription PCR detection of the
most abundantly excreted/secreted 72 h schistosomula sma-
miRNAs (sma-mir-new-215, sma-mir-new-271 and sma-
mir-new-717; bold miRNAs highlighted in Fig. 5a and b)
in infected mouse sera is currently being planned to
confirm their presence in EV-enriched and EV-depleted
host biofluids.
Polycistronic transcription of both sma-mir-71a/sma-mir-
2a and sma-mir-71b/sma-mir-2c paralogous gene clusters
could account for the presence of these known miRNAs
in schistosomula E/S products (51). This possibility pro-
mpted us to investigate whether any other schistosomula
miRNAs present in the E/S products were found arranged
in gene clusters (same orientation in the genome, less than
10 kb apart and on the same chromosome or scaffold).
Only one other miRNA cluster was identified in our study,
sma-mir-new-207/sma-mir-new-208 (both miRNAs pre-
dominantly found in the EV-depleted E/S fraction, Sup-
plementary file 3). These data, along with those previously
reported (51), would indicate that most S. mansoni miRNAs
are not transcribed as polycistronic clusters. This finding
is consistent with polycistronic analyses of other animal
miRNAs (52).
A previous study has recently reported that sma-bantam,
sma-mir-61 and the sma-mir-71b/sma-mir-2c cluster all dis-
play gender-biased expression in adult schistosomes (53).
Our identification of these gene products in schistosomula
E/S products suggests that either gender-associated miR-
NA expression is also found in larval schistosomes (54) or
that gender-biased expression of these (and other) specific
Fig. 5. Schistosomula E/S products contain large numbers of novel miRNAs found within and outside EVs. The miRDeep2 module
was used to identify 170 potential novel sma-miRNAs found within schistosomula E/S products (see Materials and methods for details).
(a) The 26 most abundant (out of 88 in total) novel sma-miRNAs found in both EV-enriched (black bars) and EV-depleted (grey bars)
fractions. (b) The 26 most abundant miRNAs more likely to be found either in the EV-enriched (44 in total) or the EV-depleted (38 in
total) E/S fractions (i.e. containing reads only in the EV-enriched or EV-depleted fractions after normalization). Bar charts represent
the miRNA log2 normalized read counts for each sample where the indicated sma-miRNA was found (see Materials and methods).
Raw and processed sma-miRNA read data are found in Supplementary file 3. Bold sma-miRNAs in (a) and (b) represent the most
abundant miRNAs found in this study.
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sma-miRNAs develops in time as also occurs for protein
coding RNAs (26). Until schistosome or host mRNA tar-
gets are experimentally identified, the functional signifi-
cance of gender-biased sma-miRNA expression in either
larval or adult schistosomes is currently unknown.
tsRNAs are found within and outside
schistosomula EVs
It is apparent that other classes of sncRNAs, in addition
to miRNAs, can play gene silencing roles and also parti-
cipate in a variety of regulatory functions in eukaryotic
transcription and translation (35,55,56). One particular
class of sncRNA gaining recognition in this regard is the
tsRNAs, which is a term used to define both tRNA halves
(tiRNAs, 3035 nucleotide 5? tRNA halves or 4050
nucleotide 3? tRNA halves generated by cleavage in the
anticodon loop) and other tRFs (1230 nucleotide 5? or 3?
fragments) (35). These tsRNAs have previously been found
in exosomal cargo derived from mammalian neuronal and
dendritic cells (57,58) and, more recently, in Leishmania
exosomes (36). We therefore postulated that schistosomu-
la E/S products derived from 72 h culture supernatants
would contain tsRNAs and that these would be found in
EV-enriched and, perhaps, EV-depleted fractions (Fig. 6).
Putative tsRNA reads from 6 (EV-enriched, n3; EV-
depleted, n3) schistosomula RNA-seq libraries were
aligned to full-length tRNA sequences and, as expected,
large numbers mapped to either the 5? or 3? ends (re-
presenting 5? tsRNAs and 3? tsRNAs, respectively) as
displayed for tRNA-SeC (Fig. 6a). Due to the small insert
sizes contained within our sncRNA libraries (range: 195
nucleotides; average: 24 nucleotides with less than 0.5%
of the reads greater than 70 nucleotides), there were no
reads that mapped with 100% coverage to full-length
S. mansoni tRNAs (the longest read found was 67 nucleo-
tides mapping to the 72 nucleotide SmtRNA-LysCTT,
representing 93% coverage). Using our strategy, we iden-
tified tsRNAs derived from 20 tRNAs (18 out of the
20 ubiquitous tRNA classes, tRNA-AA; selenocysteine
tRNA, tRNA-SeC; suppressor tRNA, tRNA-Sup) (Fig. 6b).
Notably, tsRNA reads mapping to tRNA-Tyr and tRNA-
Asn were not abundant (as defined in the Materials and
methods) and, therefore, not included in our analyses.
Both 5? and 3? tsRNAs derived from 10 tRNA classes
were found in relative equal abundance between EV-
enriched and EV-depleted fractions (Fig. 6b, G1). The
remaining 10 tRNA classes displayed contrasting patterns.
Within EV-enriched fractions, 5? tsRNAs derived from
tRNA-Arg and tRNA-Val were missing (Fig. 6b, G3), as
were 5? tsRNAs for tRNA-Sup and tRNA-Met (Fig. 6b,
G6). Within the EV-depleted fraction, 3? tsRNAs derived
from tRNA-His (Fig. 6b, G2), tRNA-Sup (Fig. 6b, G6)
and tRNA-Met (Fig. 6b, G6) were missing. Noticeably, 3?
tsRNAs derived from tRNA-Ala, tRNA-Thr, tRNA-Phe
and tRNA-Ile as well as 5? tsRNA derived from tRNA-Trp
were neither found in EV-enriched nor EV-depleted E/S
products (Fig. 6b, G4 and Fig. 6b, G5 respectively). Among
the 8 most abundant tsRNAs (tsRNA-Lys, tsRNA-Gly,
tsRNA-Gln, tsRNA-Ser, tsRNA-Asp, tsRNA-Pro, tsRNA-
Leu and tsRNA-Glu) found in schistosomula EVs (Fig. 6b),
5 of these (tsRNA-Gly, tsRNA-Gln, tsRNA-Glu, tsRNA-
Asp and tsRNA-Leu) are also the most abundant tsRNAs
found in Leishmania exosomes (36). The single most abun-
dant schistosomula E/S tsRNA (including both 5? and
3? tsRNAs) derived from tRNA-Lys is also the most
abundant tsRNA found in HeLa cell sncRNA pools (59)
and dendritic cell extracellular RNAs (58). The mechanism
by which these abundant tsRNAs are processed among
these different cells/organisms is currently unknown. The
current S. mansoni genome assembly (v5.2) does not con-
tain obvious homologs of the tRNA-processing enzymes
angiogenin or RNASE T2 (except the egg-specific omega-
1 (60)). Therefore, other molecular pathways to generate
tsRNAs may be operational within schistosomula (as
reviewed in Ref. 61).
We further quantified schistosomula 3? tsRNAs for
the presence/absence of a terminal 3? CCA tri-nucleotide
motif in order to identify those derived from mature
vs. precursor tRNAs (Fig. 6c). While differences exist in
the exact percentages of 3? tsRNAs containing a terminal
3? CCA across the 20 identified tRNA classes, our results
suggest that 54% of E/S schistosomula 3? tsRNA reads
contain this distinguishing feature. Therefore, at least half
of all E/S 3? tsRNAs are likely derived from the cleavage of
a mature tRNA. Further studies are necessary to under-
stand the significance and ubiquity (occurrence in schis-
tosomula sncRNA intracellular pools, presence in other
schistosome lifecycle stages, etc.) of our observations.
It is currently unclear why large numbers of tsRNAs are
found in schistosomula E/S products or, indeed, how they
are generated. While this could represent a consequence
of in vitro culture (stress can sometimes, but not always,
induce the cleavage of eukaryotic tRNAs (35,61)), we
contend that release of tsRNAs (and indeed miRNAs)
represents a bona fide adaptation of schistosome parasites
to subvert host defensive barriers. Determining whether
schistosomula E/S tsRNAs (containing both tiRNAs and
tRFs) can be taken up by host cells (within or outside
EVs) and affect translational inhibition and/or transcrip-
tional repression (reviewed in Ref. 56) will help shed light
on this fascinating new area of host/parasite biology.
Conclusions
S. mansoni schistosomula excrete/secrete EVs during in vitro
development and these 30100 nm sized vesicles contain
potential host-modulating proteins (109 in total), miRNAs
(205 in total) and tsRNAs (derived from 20 tRNA classes).
The description of these vesicles and their biological com-
ponents should now promote studies aiming to function-
ally characterize these new players in host interactions.
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Fig. 6. Schistosomula release tRNA-derived small RNAs (tsRNA). Reads were mapped against the S. mansoni tRNA database
depleted of mitochondrial and pseudo-tRNAs available from geneDB (34) and, using an in-house script, were characterized as 5? or
3? tsRNAs. (a) Secondary structure of smtRNA-SeC depicting characteristic cloverleaf shape composed of D-, anticodon, variable and
T-loops. Below, the coverage of RNA-seq reads mapping to smtRNA-SeC (85 nucleotides) are quantified to give an example of how
5? and 3? tsRNAs were identified for all tsRNAs (using our processing criteria, no full-length tRNAs were identified in our study).
Dashed and solid lines represent the reads mapping to smtRNA-SeC and illustrate the sequential steps (Filter 1 and Filter 2) employed
by our in-house script as outlined in the Materials and methods. The arrow represents Position 35 (U in bold), which is the terminal
nucleotide (initiating from the 5? end) used to define 5? tsRNAs (which happens to be in the anticodon loop for smtRNA-SeC).
To define 3? tsRNAs, a maximal length of 50 nt (also represented by the black arrow) initiating from the 3? tRNA end was used. Clear
read peaks can be visualized mapping to both 5? and 3? ends of tRNA-SeC. (b) Bar chart represents the tsRNAs (log2 normalized read
counts) found in EV-enriched (black bars) or EV-depleted (grey bars) supernatant fractions. G1G6 represent tsRNA groups displaying
specific associations (see text for details). (c) Stacked histogram representation of 3? tsRNAs derived from precursor tRNAs (lacking the
3? CCA trinucleotide motif; white or light grey bars, EV-enriched and EV-depleted samples, respectively) or mature tRNAs (containing
the 3? CCA trinucleotide motif; black or dark grey bars, EV-enriched and EV-depleted samples, respectively).
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